Moreover, we show for the first time that this transcript is highly expressed at the protein level in a subset of ERα-negative breast cancers, and that treatment with the ADT agent enzalutamide can induce expression of the AR gene, and consequently the AR-V7 transcript, in MDA-MB-453 cells and primary breast tumours. The gene discussed is ESR1; the disease is breast neoplasm.